Many had co-morbidities such as diabetes or coronary artery disease.Dr Rebecca Vigen and her colleagues from the University of Texas in Dallas found that the proportion of patients experiencing a stroke or heart attack three years after coronary angiography was 19.9 per cent in the no testosterone therapy group (average age, 64 years) and 25.7 per cent in the testosterone therapy group (average ag